Lung squamous cell carcinoma (LUSC) showed the highest percentage of CENPA heterozygous amplification with no instances of heterozygous deletion, aligning with the earlier observation of a high frequency of gene amplification in lung cancer. This evidence concerns the gene CENPA and lung cancer.